Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4452530
Max Phase: Preclinical
Molecular Formula: C41H52ClN11O13
Molecular Weight: 942.38
Molecule Type: Unknown
Associated Items:
ID: ALA4452530
Max Phase: Preclinical
Molecular Formula: C41H52ClN11O13
Molecular Weight: 942.38
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)CC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N2CC(CCl)c3c2cc(O)c2[nH]c(C(N)=O)cc32)cc1
Standard InChI: InChI=1S/C41H52ClN11O13/c1-18(2)32(52-29(55)11-9-24(38(62)63)50-41(66)51-25(39(64)65)10-12-30(56)57)36(60)49-23(4-3-13-46-40(44)45)35(59)47-21-7-5-19(6-8-21)37(61)53-17-20(16-42)31-22-14-26(34(43)58)48-33(22)28(54)15-27(31)53/h5-8,14-15,18,20,23-25,32,48,54H,3-4,9-13,16-17H2,1-2H3,(H2,43,58)(H,47,59)(H,49,60)(H,52,55)(H,56,57)(H,62,63)(H,64,65)(H4,44,45,46)(H2,50,51,66)/t20?,23-,24-,25-,32-/m0/s1
Standard InChI Key: VZDMODJDEIAICS-YLRAJGTISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 942.38 | Molecular Weight (Monoisotopic): 941.3435 | AlogP: 0.63 | #Rotatable Bonds: 23 |
Polar Surface Area: 401.65 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 14 |
#RO5 Violations: 3 | HBA (Lipinski): 24 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.03 | CX Basic pKa: 14.34 | CX LogP: -3.24 | CX LogD: -9.69 |
Aromatic Rings: 3 | Heavy Atoms: 66 | QED Weighted: 0.03 | Np Likeness Score: -0.19 |
1. Beekman AM, Cominetti MMD, Cartwright OC, Boger DL, Searcey M.. (2019) A small molecule drug conjugate (SMDC) of DUPA and a duocarmycin built on the solid phase., 10 (12): [PMID:32879717] [10.1039/C9MD00279K] |
Source(1):